While WNT5A is considered to have a tumor-suppressive function in colon cancer [17], neuroblastoma [18], breast carcinomas [19], and leukemia [20], it has also been shown to promote progression of gastric cancer [21], melanoma [22], lung [23] and pancreatic cancer [24]. Here, WNT5A is linked to breast carcinoma.